Fiche publication
Date publication
juillet 2026
Journal
Journal of Crohn's & colitis
Auteurs
Membres identifiés du Cancéropôle Est :
Dr VUITTON Lucine
Tous les auteurs :
Caron B, Kirchgesner J, Nachury M, Bouguen G, Uzzan M, Buisson A, Le Cosquer G, Vuitton L, Seksik P, Petit S, Wils P, Nancey S, Altwegg R, Hupe M, Fumery M, Roblin X, Laharie D, Hebuterne X, Baumann C, Vicaut E, Peyrin-Biroulet L
Lien Pubmed
Résumé
Methotrexate has demonstrated efficacy in Crohn's disease (CD) as monotherapy and is increasingly used in combination therapy. We investigated for the first time the use of methotrexate in a very large cohort of patients with inflammatory bowel disease (IBD) in a real-world setting.
Mots clés
inflammatory bowel disease, methotrexate, persistence, safety
Référence
J Crohns Colitis. 2026 07 7;20(7):
